Medication info
Synergist ER Tablets

Synergist ER Tablets

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›75mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
Pale yellow oblong film-coated extended-release tablet
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 201306118 · Approved 2013.03.08 · Insurance code 647803730

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. The recommended initial dose is 1 tablet. Thereafter, doses should be given at intervals of at least 12 hours, and no more than 4 tablets should be taken in 1 day. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur when taking this medicine; monitor the patient's response closely and adjust treatment appropriately. Older adults: Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to older adults aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. The recommended initial dose is 1 tablet. Thereafter, doses should be given at intervals of at least 12 hours, and no more than 4 tablets should be taken in 1 day. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur when taking this medicine; monitor the patient's response closely and adjust treatment appropriately. Older adults: Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to older adults aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Precautions

This medication may cause liver damage if taken by individuals who regularly consume more than three alcoholic beverages per day, so consult a doctor or pharmacist before use. One of the ingredients in this medication can, rarely, cause dangerous skin reactions such as serious rashes, blisters, or severe skin necrosis, and if any rash or allergic symptoms appear after taking this medication, discontinue use immediately. Taking tramadol beyond the recommended dosage may increase the risk of seizures, especially when combined with certain antidepressants or other narcotic analgesics. Rarely, serious allergic reactions may occur while taking this medication, so if sudden difficulty in breathing or hives occur, notify healthcare professionals immediately. When administering this medication to patients with acute bronchial asthma, there is a risk of severe respiratory suppression, so it must be administered with careful monitoring in a facility equipped with medical equipment. Combining this medication with alcohol or central nervous system depressants can lead to severe drowsiness, respiratory suppression, coma, or death, thus extreme caution is required when used in conjunction with such substances. Patients with head injuries or brain diseases should be cautious, as taking this medication may increase the risk of raised intracranial pressure and respiratory suppression. This medication can cause both psychological and physical dependence, so long-term users should closely monitor for signs of dependency. Patients with impaired liver function should consult a doctor before taking this medication due to the risk of liver damage from acetaminophen, one of its ingredients. Patients with certain genotypes may metabolize this medication rapidly, resulting in higher blood levels of the active ingredients and an increased risk of respiratory suppression; dosage adjustment and symptom monitoring are necessary for these patients. This medication should not be administered to children under 12 years old or adolescents under 18 who have undergone tonsillectomy or adenoidectomy, and adolescents aged 12 to 18 with special risk factors should also avoid taking the drug. Low sodium levels in the blood (hyponatremia) can occur during the use of this medication, and especially in elderly patients or those with risk factors, regular blood tests and symptom monitoring are required. This medication should not be taken by individuals who have hypersensitivity to certain ingredients, who are intoxicated by central nervous system agents, who are suffering from severe respiratory depression, who have head injuries, who have taken MAO inhibitors within the last 14 days, or who have severe liver, kidney, or heart dysfunction, as well as children under 12 years of age, and nursing mothers. Dependency and withdrawal symptoms can occur when this medication is used in combination with other opioid medications, so patients with opioid dependence should avoid its use. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as anxiety, insomnia, sweating, nausea, and tremors; therefore, the dosage should be gradually reduced according to a doctor's instructions when discontinuing. This medication may cause drowsiness or dizziness, so caution should be exercised after taking it when driving or operating machinery. In case of overdose, respiratory suppression, coma, and liver damage may occur, making it essential to seek emergency treatment immediately, and, if necessary, the administration of an antidote should be undertaken. Do not exceed the recommended dosage while taking this medication, and do not take it in combination with other tramadol or acetaminophen products. Particularly for pregnant or nursing mothers, care should be taken to consider the effects on the fetus or newborn when using this medication, and nursing may need to be discontinued or the drug administration stopped.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, syncope, withdrawal symptoms, hypertension, worsening hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremor, ataxia, convulsions, hypertonia, migraine, exacerbation of migraine, involuntary muscle contractions, paresthesia, confusion, dizziness, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, decreased appetite, anxiety, confusion, euphoria, insomnia, neuroticism, drowsiness, forgetfulness, depersonalization, depression, drug abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thinking, anemia, dyspnea, proteinuria, urination disorders, oliguria, urinary retention, pruritus, rash, sweating, urticaria, liver function abnormalities, weight loss, tinnitus, abnormal vision, chills, vasodilation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, bronchospasm, wheezing, angioedema, allergic reactions, changes in appetite, exercise intolerance, respiratory depression, cognitive dysfunction, difficulty concentrating, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, withdrawal symptoms, delirium, miosis, mydriasis, speech disorders, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, thrombocytopenia, agranulocytosis, hypoprothrombinemia, propylene glycol acidosis, weakness, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exertional dyspnea, cough, bronchitis, hematuria, increased blood pressure, palpitations, irregular menstruation, bleeding, elevated cholesterol, hip pain, thigh pain, allergic rhinitis, epistaxis, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, cholecystitis, paralytic ileus, abnormal renal function parameters, increased saliva, hiccups, drowsiness, insomnia, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, aortic stenosis, nausea, vomiting, cold sweat, pruritus, urticaria, headache, constipation, dyspepsia, decreased appetite, dizziness, drowsiness, thirst, dry mouth, hyperhidrosis, rash, urination disorders, abdominal pain, insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain storage temperatures between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow oblong film-coated extended-release tablet

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.